UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 207

Sortiert nach

Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse

BMC neuroscience, 2010-10, Vol.11 (1), p.130-130, Article 130

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline

Scientific reports, 2017-08, Vol.7 (1), p.8009-12, Article 8009

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma BDNF levels vary in relation to body weight in females

PloS one, 2012-07, Vol.7 (7), p.e39358-e39358

2012

Link zum Volltext

Verfügbarkeit prüfen

Blocking the Apolipoprotein E/Amyloid-β Interaction as a Potential Therapeutic Approach for Alzheimer's Disease

Proceedings of the National Academy of Sciences - PNAS, 2006-12, Vol.103 (49), p.18787-18792

2006

Link zum Volltext

Verfügbarkeit prüfen

Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits

The Journal of neuroscience, 2017-01, Vol.37 (4), p.936-959

2017

Link zum Volltext

Verfügbarkeit prüfen

High-affinity rabbit monoclonal antibodies specific for amyloid peptides amyloid-β40 and amyloid-β42

Journal of Alzheimer's disease, 2011, Vol.23 (2), p.293

2011

Link zum Volltext

Verfügbarkeit prüfen

Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology

Journal of neurochemistry, 2014-02, Vol.128 (4), p.577-591

2014

Link zum Volltext

Verfügbarkeit prüfen

Bone mineral density, adiposity, and cognitive functions

Frontiers in aging neuroscience, 2015-02, Vol.7, p.16-16

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque

Journal of neuropathology and experimental neurology, 2005-02, Vol.64 (2), p.139-146

2005

Link zum Volltext

Verfügbarkeit prüfen

Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder

The American journal of psychiatry, 2012-05, Vol.169 (5), p.523-530

2012

Link zum Volltext

Verfügbarkeit prüfen

Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease

Journal of Alzheimer's disease, 2010-01, Vol.22 (2), p.569

2010

Link zum Volltext

Verfügbarkeit prüfen

Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation

Acta neuropathologica communications, 2014-09, Vol.2 (1), p.101, Article 101

2014

Link zum Volltext

Verfügbarkeit prüfen

Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints

Biological psychiatry (1969), 2008-03, Vol.63 (6), p.609-618

2008

Link zum Volltext

Verfügbarkeit prüfen

Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

Neurobiology of aging, 2004-11, Vol.25 (10), p.1263-1272

2004

Link zum Volltext

Verfügbarkeit prüfen

Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice

The American journal of pathology, 2001-08, Vol.159 (2), p.439-447

2001

Link zum Volltext

Verfügbarkeit prüfen

Biological markers for therapeutic trials in Alzheimer’s disease: Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer’s disease

Neurobiology of aging, 2003-07, Vol.24 (4), p.521-536

2003

Link zum Volltext

Verfügbarkeit prüfen

Increased amyloid β protein levels in children and adolescents with Down syndrome

Journal of the neurological sciences, 2007-03, Vol.254 (1), p.22-27

2007

Link zum Volltext

Verfügbarkeit prüfen

Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same?

Annals of neurology, 2005-07, Vol.58 (1), p.139-142

2005

Link zum Volltext

Verfügbarkeit prüfen

Aβ40 and Aβ42 levels in plasma: Comparison of enzyme-linked immunosorbent assay (ELISA) with multiplex technology

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P507-P507

2015

Link zum Volltext

Verfügbarkeit prüfen

DISEASE MODIFYING THERAPY BY THE INFUSION OF AN ANTI-CONFORMATIONAL MONOCLONAL ANTIBODY IN AN AB AND TAU 3XTG MOUSE MODEL OF ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P360-P360

2016

Link zum Volltext

Verfügbarkeit prüfen

Amyloid beta protein as a marker or risk factor of Alzheimer's disease

Current Alzheimer research, 2007-09, Vol.4 (4), p.359

Mehta, Pankaj D

2007

Link zum Volltext

Verfügbarkeit prüfen

Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels

Neurobiology of aging, 2012, Vol.33 (1), p.199.e13-199.e17

2012

Link zum Volltext

Verfügbarkeit prüfen

Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer's

Biological psychiatry (1969), 2010-11, Vol.68 (10), p.913-921

2010

Link zum Volltext

Verfügbarkeit prüfen

PYROGLUTAMATE-3 AMYLOID-BETA PROTEIN PLASMA LEVELS IN DOWN SYNDROME (DS)

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P800-P800

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 207

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline

Plasma BDNF levels vary in relation to body weight in females

Blocking the Apolipoprotein E/Amyloid-β Interaction as a Potential Therapeutic Approach for Alzheimer's Disease

Abnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders

Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits

High-affinity rabbit monoclonal antibodies specific for amyloid peptides amyloid-β40 and amyloid-β42

Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology

Bone mineral density, adiposity, and cognitive functions

Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque

Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder

Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease

Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation

Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints

Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice

Biological markers for therapeutic trials in Alzheimer’s disease: Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer’s disease

Increased amyloid β protein levels in children and adolescents with Down syndrome

Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same?

Aβ40 and Aβ42 levels in plasma: Comparison of enzyme-linked immunosorbent assay (ELISA) with multiplex technology

DISEASE MODIFYING THERAPY BY THE INFUSION OF AN ANTI-CONFORMATIONAL MONOCLONAL ANTIBODY IN AN AB AND TAU 3XTG MOUSE MODEL OF ALZHEIMER’S DISEASE

Amyloid beta protein as a marker or risk factor of Alzheimer's disease

Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels

Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer's

PYROGLUTAMATE-3 AMYLOID-BETA PROTEIN PLASMA LEVELS IN DOWN SYNDROME (DS)

Suchergebnisse filtern